| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 02/05/1997 | EP0757038A1 Benzamide compound and medicinal use thereof |
| 02/05/1997 | EP0708778B1 Imidazo[1,2-a]pyrazin-4-one derivatives for use as ampa and nmda receptor antagonists |
| 02/05/1997 | EP0666850B1 1,2,3,5,6,7,8,8a-OCTAHYDRO-5,5,8a-TRIMETHYL-(8aBETA)-6-ISOQUINOLINEAMINE DERIVATIVES, PREPARATION METHOD THEREFOR AND THERAPEUTICAL USE THEREOF |
| 02/05/1997 | EP0527879B1 Synergistic therapeutic compositions and methods |
| 02/05/1997 | CN1142227A Novel thiazolidin-4-one derivatives |
| 02/05/1997 | CN1142189A Platelet-special chimeric immunoglobulin and methods of use thereof |
| 02/05/1997 | CN1142184A Antiarrhythmic benzodiazepines |
| 02/05/1997 | CN1141921A Chromone derivative |
| 02/05/1997 | CN1141919A Endotheliomycine receptor antagonist |
| 02/05/1997 | CN1141809A Method for treatment of undissolved thrombus acute myocardinal infraction by using hirudin and acetylsalicylic acid |
| 02/05/1997 | CN1141805A Chinese medicine for treatment of angiitis |
| 02/05/1997 | CN1033976C Preparation of polypeptides used as blockers of calcium channels |
| 02/05/1997 | CN1033972C Method for preparing 2H-1-benzopyran compound |
| 02/04/1997 | US5599984 Guanylhydrazones and their use to treat inflammatory conditions |
| 02/04/1997 | US5599937 Heteroaromatic quinuclidinenes, their use and preparation |
| 02/04/1997 | US5599844 Administering agent to elevate level of transforming growth factor beta |
| 02/04/1997 | US5599833 Sulfonate and carbamate derivatives of 3-aroylbenzo[B]thiophenes |
| 02/04/1997 | US5599830 Sulphorous derivatives of imidazole and their use as medicaments |
| 02/04/1997 | US5599824 Pharmaceutical preparation containing a specific crystal modification of isopropyl-(2-methoxyethyl) 1,4-dihydro-2, 6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate |
| 02/04/1997 | US5599823 Substituted biphenylpyridones |
| 02/04/1997 | US5599814 Pyridazinedione compounds useful in treating neurological disorders |
| 02/04/1997 | US5599811 Phenyl or dioxyphenyl substituents; drugs |
| 02/04/1997 | US5599810 Furo- and thieno[4,3,2-ef][3]benzazepines useful as alpha adrenergic receptor antagonists |
| 02/04/1997 | US5599806 Hydrazino and hydroxyamino-14-β-hydroxyandrostane derivatives active on the cardiovascular system processes for their preparation and pharmaceutical compositions containing same |
| 02/04/1997 | US5599793 Anticoagulants |
| 02/04/1997 | US5599706 Ribozymes targeted to apo(a) mRNA |
| 02/04/1997 | US5599559 Calcium channel blocking polypeptide from agelenopsis aperta and therapeutic methods employing it |
| 02/03/1997 | CA2182469A1 Endothelin-receptor-antagonists |
| 01/30/1997 | WO1997003188A2 Use of mp52 or mp121 for treating and preventing diseases of the nervous system |
| 01/30/1997 | WO1997003084A1 New inhibitors of platelet aggregation |
| 01/30/1997 | WO1997003079A1 Novel quinoxaline- and quinoxalinylalkane-phosphonic acids |
| 01/30/1997 | WO1997003071A1 Heterocyclylcarboxamide derivatives and their use as therapeutic agents |
| 01/30/1997 | WO1997003069A1 Heterocyclic compounds and pharmaceutical compositions containing them |
| 01/30/1997 | WO1997003067A1 Piperazine derivatives as therapeutic agents |
| 01/30/1997 | WO1997002816A1 Use of pyruvate for retarding neutrophil infiltration and morphologic loss in ischemic bowel |
| 01/30/1997 | CA2226758A1 New inhibitors of platelet aggregation |
| 01/30/1997 | CA2224718A1 Novel quinoxaline- and quinoxalinylalkane-phosphonic acids |
| 01/30/1997 | CA2223472A1 Therapeutic agents |
| 01/29/1997 | EP0755934A1 Endothelin receptor antagonists |
| 01/29/1997 | EP0755930A1 Benzoxazepine derivatives, salts thereof, and drugs containing the same |
| 01/29/1997 | EP0755925A1 N,N'-di(aralkyl)-N,N'-di(2-azaaralkyl)alkylene-diamine derivatives and their use in pharmaceutical and cosmetic compositions |
| 01/29/1997 | EP0755919A2 Substituted cinnamic acid guanidides, process for their preparation, their use as cardiovascualr medicament or diagnostic agent, as well as medicament containing them |
| 01/29/1997 | EP0755917A1 N,N'-di(aralkyl) N,N'-di(carboxyalkyl) alkylen- di- or triamino-derivatives and N-(aralkyl) N'-(carboxyalkyl) N,N'-di (carboxyalkyl) alkylen- di- or triamino-derivatives and their use in pharmacy and cosmetics |
| 01/29/1997 | EP0755408A1 Peptides for reducing or inhibiting bone resorption, angiogenesis and restenosis |
| 01/29/1997 | EP0755404A1 Tachykinin antagonists |
| 01/29/1997 | EP0755265A1 The combination of growth hormone and insulin-like growth factor, for treating congestive heart failure |
| 01/29/1997 | EP0755264A1 Treatment of congestive heart failure |
| 01/29/1997 | EP0755262A1 Composition for the treatment of lung disease |
| 01/29/1997 | EP0675878B1 Novel vitamin d analogues |
| 01/29/1997 | EP0652755B1 Therapeutic use of phosphoryl-l-serine-n-acyl-sphingosine |
| 01/29/1997 | EP0651741B1 Ng-monomethyl-l-arginine hydrochloride derivatives and process for their preparation |
| 01/29/1997 | EP0641769B1 Amino acid derivative |
| 01/29/1997 | EP0635015B1 Acylaminoindole derivatives as 5-ht1 agonists |
| 01/29/1997 | EP0633878B1 Novel vitamin d analogues |
| 01/29/1997 | EP0544748B1 Spiro[cycloalkylbenzene-1,1'-(1',2',3',4'-tetrahydroisoquinolines)] having neuroprotective properties |
| 01/29/1997 | EP0501997B1 N-acyl-substituted azacyclic compounds, processes for their preparation, and their use as pharmaceuticals |
| 01/29/1997 | CN1141637A Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof |
| 01/29/1997 | CN1141630A Substituted pyrazolyl benzenesulfonamides for treating inflammation |
| 01/29/1997 | CN1141625A Vitamin D amine and amine derivatives |
| 01/29/1997 | CN1141590A Agent for prophylaxis and treatment of thromboxane A2-mediated diseases |
| 01/29/1997 | CN1141291A 4-(Arylaminomethylene)-2,4-dihydro-3-pyrazolones |
| 01/29/1997 | CN1141191A Styracol tablet |
| 01/29/1997 | CA2182156A1 Endothelin-receptor-antagonists |
| 01/28/1997 | US5597915 Antagonists of cholecystokinin and gastrin receptors |
| 01/28/1997 | US5597847 Nitric esters of derivatives of the 2-(2,6-di-halo-phenylamino) phenylacetic acid and process for their preparation |
| 01/28/1997 | US5597832 Tetracyclic compounds as dopamine agonists |
| 01/28/1997 | US5597828 Certain 2,4-diamino-5-(2,3-dihalophenyl)-6-substituted pyrimidines which are pharmacologically active CNS compounds |
| 01/28/1997 | US5597827 Treatment of injury of the spinal cord or brain using 4-amino-2-(4-methylpiperazin-1-yl)-5-(2,3,5-trichlorophenyl)pyrimidine |
| 01/28/1997 | US5597826 Compositions containing sertraline and a 5-HT1D receptor agonist or antagonist |
| 01/28/1997 | US5597819 Antiinflammatory agents |
| 01/28/1997 | US5597818 Methods of treating cardiac arrhythmia |
| 01/28/1997 | US5597816 Pyrazoloazepino substituted oximes useful as anti-atherosclerosis and anti-hypercholesterolemic agents |
| 01/28/1997 | US5597800 Treatment with lys-plasminogen of reperfusion injury and brain edema caused by ischemia |
| 01/28/1997 | CA2181422A1 Fenofibrate galenic formulations and uses thereof |
| 01/28/1997 | CA2061270C Method and composition for treating reperfusion injury |
| 01/27/1997 | CA2182113A1 N,n'-di(aralkyl) n,n'-di(2-azaaralkyl) alkylene diamine derivatives and their use in pharmaceutical and cosmetic compositions |
| 01/27/1997 | CA2182112A1 N,n'-di(aralkyl) n,n'-di(carboxyalkyl) alkylene di- or triamine and n-(aralkyl) n'-(carboxyalkyl) n,n'-di(carboxyalkyl) alkylene di- or triamine derivatives and their use in pharmaceutical or cosmetic applications |
| 01/23/1997 | WO1997002259A1 1,6-disubstituted isochromans for treatment of migraine headaches |
| 01/23/1997 | WO1997002254A1 Quinazoline derivatives |
| 01/23/1997 | WO1997002250A1 10-ACYLOXY-10,11-DIHYDRODIBENZ/b,f/AZEPINE-5-CARBOXAMIDES USEFUL FOR TREATING NERVOUS SYSTEM DISORDERS |
| 01/23/1997 | WO1997002242A1 Azetidinone derivatives for the treatment of atherosclerosis |
| 01/23/1997 | WO1997002037A1 Compounds and pharmaceutical compositions containing them |
| 01/23/1997 | WO1997002036A1 4-(2-(n-2-carboxamidoindole)aminoethyl)-benzenesulfonamides or sulfonylureas as pdgf antagonists |
| 01/23/1997 | WO1997000063A3 Urocortin peptides |
| 01/23/1997 | WO1996040258A3 Spironolactone and angiotensin ii antagonist combination therapy for treatment of congestive heart failure |
| 01/23/1997 | WO1996040250A3 Platelet-specific chimeric immunoglobulin and methods of use therefor |
| 01/23/1997 | WO1996038558A3 A human purinergic p2u receptor |
| 01/23/1997 | WO1996028151A3 Use of a pyruvate dehydrogenase activator for the treatment of ischaemia in limbs |
| 01/23/1997 | CA2225627A1 Azetidinone derivatives for the treatment of atherosclerosis |
| 01/23/1997 | CA2225391A1 Compounds and pharmaceutical compositions containing them |
| 01/23/1997 | CA2225282A1 1,6-disubstituted isochromans for treatment of migraine headaches |
| 01/22/1997 | EP0754688A2 Dioxolane intermediates |
| 01/22/1997 | EP0754680A1 4-Fluoroalkyl-substituted benzoylguanidines, process for their preparation, their use as medicament or diagnostic as well as medicaments containing them |
| 01/22/1997 | EP0754234A1 DNA ENCODING PRECURSOR OF INTERLEUKIN-1BETA CONVERTING ENZYME-RELATED CYSTEINE PROTEINASE II (ICE rel-II) |
| 01/22/1997 | EP0754190A1 An equilin double bond isomer from the acid isomerization of equilin |
| 01/22/1997 | EP0754187A1 Growth arrest homeobox gene |
| 01/22/1997 | EP0754054A1 Antirestenosis protein |
| 01/22/1997 | EP0754053A1 Novel hemostatic composition |
| 01/22/1997 | EP0754043A1 Inhibition of smooth muscle cell migration by (r)-amlodipine |
| 01/22/1997 | EP0754042A1 Treatment of atherosclerosis with angiotensin ii receptor blocking imidazoles |